Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Carol A. Jacobsen"'
Autor:
Virginia C. Fiedler, Nicholas J. Lowe, Richard L. DeVillez, Toni Funicella, Bruce Binkowitz, Elise A. Olsen, Jerome L. Shupack, Anne W. Lucky, Patrick R. Carrington, Glenn J. Gormley, Maria K. Hordinsky, Julianne Imperato-McGinley, James M. Swinehart, Darryl Weiss, Elizabeth Whitmore, Sigfrid A. Muller, Christopher Gencheff, Vera H. Price, Carol A. Jacobsen, Lisa Terranella, Lynn A. Drake, Keith D. Kaufman, Ronald C. Savin, Weili He, Paul Kotey, Dowling B. Stough, Irving Katz, Larry E. Millikan, David A. Whiting, Janet L. Roberts, Robert L. Rietschel, Karen Bruno, Wilma F. Bergfeld
Publikováno v:
Journal of the American Academy of Dermatology. 41:555-563
Background: Androgenetic alopecia is a common condition of adult men. Finasteride, a type 2 5α-reductase inhibitor, decreases the formation of dihydrotestosterone from testosterone. Objective: Two separate clinical studies were conducted to establis
Autor:
Wayne Hellstrom, Phillip Toth, Sander Shapiro, James W. Overstreet, Daniel Z. Wang, Stuart S. Howards, Carol A. Jacobsen, Keith D. Kaufman, Ronald Lewis, Michael M. Lieber, Tom Shown, Jonathan P. Jarow, Steven Petrou, Jaime Bonilla, Randle S. Corfman, Peter Carroll, Johnny Roy, John Gould, Vivian L. Fuh
Publikováno v:
The Journal of Urology. :1295-1300
Purpose: Finasteride, an oral type 2, 5α-reductase inhibitor, is used in 1 mg. daily doses for the treatment of male pattern hair loss. A dose of 5 mg. finasteride daily reduces ejaculate volume by approximately 25%, and reduces prostate volume by a
Autor:
T. Hald, Hans Hedlund, Reginald C. Bruskewitz, Paul Abrams, Mark A. Bach, Werner Schäfer, A. Matos-Ferriera, Carol A. Jacobsen, Teuvo L.J. Tammela, A. Cannon, David M. Barrett, Jørgen Nordling, Paul Miller, J.T. Andersen, S. Mustonen, H.J. Rollema, Marie-Pierre Malice
Publikováno v:
Urology. 54:278-283
Objectives. To assess the long-term effects of finasteride on pressure-flow parameters in men with urodynamically documented bladder outflow obstruction (BOO). Methods. One hundred twenty-one men with benign prostatic enlargement (BPE) and lower urin
Autor:
Glenn J. Gormley, Roger S. Kirby, April M. Cannon, Teuvo L.J. Tammela, Mark A. Bach, David M. Barrett, Marie-Pierre Malice, A. Matos-Ferreira, S. Mustonen, R. Bruskewitz, Paul Miller, Hans Hedlund, Tage Hald, J.T. Andersen, Werner Schäfer, Carol A. Jacobsen, J. Nordling, Harm J. Rollema, Paul Abrams
Publikováno v:
The Journal of Urology. :1513-1517
Purpose: We assess the effect of finasteride, a 5 alpha-reductase inhibitor, on objective voiding parameters in men with lower urinary tract symptoms and benign prostatic enlargement on digital rectal examination (known as clinical benign prostatic e
Autor:
Sidney Rosenblatt, Jack Geller, John Trachtenberg, Gholam H. Malek, Michael M. Lieber, Mostafa M. Elhilali, Perinchery Narayan, Elizabeth Stoner, Reginald C. Bruskewitz, Johnny B. Roy, Amy T Ko, Nicholas A. Romas, Carol A. Jacobsen, Perry B. Hudson, Jean-Paul Perreault, Lynn A. Patterson, Richard Norman, Rex Boake
Publikováno v:
Urology. 53:690-695
Objectives. The purpose of this open-label study extension was to assess the long-term safety and efficacy of finasteride in the treatment of men with benign prostatic hyperplasia (BPH). Methods. A Phase III North American BPH trial originally enroll
Autor:
Jørgen Nordling, Paul Abrams, Carol A. Jacobsen, Roger S. Kirby, Hans Hedlund, J.T. Andersen, Teuvo L.J. Tammela, Mark A. Bach, Reginald C. Bruskewitz, Glenn J. Gormley, David M. Barrett, Harm J. Rollema, Paul Miller, Werner Schäfer, A. Matos-Ferreira, Marie-Pierre Malice
Publikováno v:
Neurourology and Urodynamics. 18:17-24
Test-retest reliability of repeated voids in pressure-flow studies and the influence on maximum flow rate (QmaxpQ), detrusor pressure at maximum flow rate (pdetQmax), voided volume, and residual urine were studied. Also the agreement in interpretatio
Autor:
Kevin Graham, Carlos A. Dujovne, Peter O. Kwiterovich, Sharon Ames, Thomas G. Brewster, D. Roger Illingworth, Evan A. Stein, Martti A. Siimes, Jonathan L. Isaacsohn, Chris A. Liacouras, Carol A. Jacobsen, Christine L. Williams, Frederick Arensman, Paul N. Hopkins, Robert H. Knopp, Marc S. Jacobson, Michael H. Davidson, Peter M. Laskarzewski, Glenn J. Gormley
Publikováno v:
JAMA. 281(2)
ContextHeterozygous familial hypercholesterolemia (HeFH) is a common disorder associated with early coronary artery disease, especially in men. The age at which drug therapy should be started is still controversial, as is the use of 3-hydroxy-3-methy
Autor:
Eugene L. Dulaney, Carol A. Jacobsen
Publikováno v:
The Journal of antibiotics. 40(8)
Autor:
Eugene L. Dulaney, Carol A. Jacobsen
Publikováno v:
The Journal of Antibiotics. 41:982-983